Skip to content

Active ingredient

Clindamycin

212 finished FDA listings contain Clindamycin as their only active ingredient; 31 combination products also contain it.

FDA NDC Directory

Ingredient names as written by FDA
CLINDAMYCIN, CLINDAMYCIN HYDROCHLORIDE, CLINDAMYCIN PALMITATE, CLINDAMYCIN PALMITATE HYDROCHLORIDE, CLINDAMYCIN PHOSPHATE
Dosage forms
Aerosol, Foam, Capsule, Capsule, Gelatin Coated, Cream, Gel, Granule, For Solution, Injection, Solution, Lotion, Powder, For Solution, Solution, Suppository, Swab
Routes
Intramuscular, Intravenous, Oral, Topical, Vaginal
Manufacturers / labelers
68
Strengths listed
1 g/100ml · 1 g/10ml · 10 mg/1 · 10 mg/g · 10 mg/ml · 10 ug/ml · 100 mg/1 · 100 mg/5g · 11.9 mg/ml · 12 mg/ml · 150 mg/1 · 150 mg/ml · 18 mg/ml · 20 mg/g · 300 mg/1 · 300 mg/50ml · 6 mg/ml · 600 mg/50ml · 75 mg/1 · 75 mg/5ml · 900 mg/50ml
Brand names in FDA listings
Cleocin, Cleocin Hydrochloride, Cleocin Pediatric, Cleocin Phosphate, Cleocin T, Clindacin, Clindacin Etz, Clindacin P, Clindagel, Clindamycin, Clindamycin In 5 Percent Dextrose, Clindamycin Palmitate Hydrochloride (Pediatric), Clindamycin Phoaphate Topical Solution Usp, 1%, Clindamycin Phoaphate Topical Usp, 1%, Clindamycin Phosphate, Clindesse, Xaciato

RxNorm (National Library of Medicine)

Ingredient concept RxCUI 2582

Drugs@FDA applications

Linked only where the FDA listing’s application number matches Drugs@FDA exactly. A listing in the NDC Directory does not by itself mean FDA approval.

ApplicationSponsorOriginal approvalListings
NDA 050162PFIZER1970-02-223
NDA 050441PFIZER1972-10-0212
NDA 050615PFIZER1987-01-071
NDA 050600PFIZER1989-05-312
NDA 050680PFIZER1992-08-112
ANDA 064050PADAGIS US1995-11-307
ANDA 064160FOUGERA PHARMS2000-01-281
ANDA 065049PADAGIS US2000-05-254
NDA 050782BAUSCH2000-11-272
ANDA 065061SUN PHARM INDS LTD2001-02-0225
ANDA 065067FOUGERA PHARMS2002-01-312
ANDA 065194EPIC PHARMA LLC2004-03-221
ANDA 065184TARO PHARM INDS2004-03-312
ANDA 065139FOUGERA PHARMS2004-12-271
ANDA 065243CHARTWELL MOLECULAR2005-08-123
ANDA 065442AUROBINDO PHARMA2009-08-2611
ANDA 090785PADAGIS ISRAEL2010-03-314
ANDA 065513EPIC PHARMA LLC2010-06-171
ANDA 090108SAGENT PHARMS INC2011-09-305
ANDA 201692SANDOZ INC2012-05-315
ANDA 201821RISING2012-08-283
ANDA 202409AUROBINDO PHARMA LTD2013-04-302
NDA 208083BAXTER HLTHCARE CORP2017-04-203
ANDA 208084BAXTER HLTHCARE CORP2017-06-287
ANDA 209846CHARTWELL RX2018-02-082
ANDA 208767ZYDUS LIFESCIENCES2018-07-163
ANDA 207402MICRO LABS2018-11-0527
ANDA 209914ENCUBE ETHICALS2019-01-283
ANDA 210004TARO2020-03-111
ANDA 211872AMVIKA2020-07-291
ANDA 212104PADAGIS ISRAEL2020-12-315
ANDA 214251GLENMARK PHARMS LTD2021-02-103
ANDA 214604PADAGIS ISRAEL2021-03-085
ANDA 212438ENCUBE2021-03-113
ANDA 214526SUN PHARMA CANADA2021-06-282
ANDA 210778GLENMARK PHARMS LTD2021-09-201
ANDA 216957GLENMARK PHARMS LTD2023-03-1024
ANDA 214401HIKMA2023-04-053
ANDA 216587ZYDUS LIFESCIENCES2023-09-192
ANDA 212466ALEMBIC2024-04-022

Showing 40 of 56 applications.

Official labeling on DailyMed

Showing the 12 most recent of 174 labels.

Sources: FDA NDC Directory (2026-09-29), RxNorm, Drugs@FDA, DailyMed. Each source’s facts are shown separately as published.